Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 2, 2004, Pages 395-400

  Tell, Roger ^a   Lundell, Göran ^a   Nilsson, Bo ^a   Sjödin, Helena ^a   Lewin, Freddi ^a   Lewensohn, Rolf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Head and neck cancer; Hypothyroidism; Radiotherapy

Indexed keywords

DISEASES; HORMONES; ONCOLOGY; SURGERY;

HYPOTHYROIDISM; MULTIVARIATE ANALYSIS; NECK CANCER; THYROID;

RADIOTHERAPY;

THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HORMONE SUBSTITUTION; HOSPITAL ADMISSION; HUMAN; HYPOTHYROIDISM; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID GLAND;

EID: 4544325102     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.03.020     Document Type: Article

References (49)

1. Beling U., Einhorn J. Incidence of hypothyroidism and recurrences following I-131 treatment of hyperthyroidism. Acta Radiol. 56:1961;275-288
2. Einhorn J., Wicklund H. Hypothyroidism following 131-I treatment for hyperthyroidism. J Clin Endocrinol Metab. 26:1966;33-36
3. Einhorn J., Wikholm G. Hypothyroidism after external irradiation to the thyroid region. Radiology. 88:1967;326-328
4. Constine L.S., Donaldson S.S., McDougall I.R., et al. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer. 53:1984;878-883
5. Kaplan M.M., Garnick M.B., Gelber R., et al. Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. Am J Med. 74:1983;272-280
6. Hancock S.L., Cox R.S., McDougall I.R. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med. 325:1991;599-605
7. Posner M.R., Ervin T.J., Miller D., et al. Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck. Laryngoscope. 94:1984;451-454
8. Vrabec D.P., Heffron T.J. Hypothyroidism following treatment for head and neck cancer. Ann Otol Rhinol Laryngol. 90:1981;449-453
9. Sklar C., Whitton J., Mertens A., et al. Abnormalities of the thyroid in survivors of Hodgkin's disease Data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 85:2000;3227-3232
10. Nishiyama K., Tanaka E., Tarui Y., et al. A prospective analysis of subacute thyroid dysfunction after neck irradiation. Int J Radiat Oncol Biol Phys. 34:1996;439-444
11. Mercado G., Adelstein D.J., Saxton J.P., et al. Hypothyroidism A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer. 92:2001;2892-2897
12. Grande C. Hypothyroidism following radiotherapy for head and neck cancer Multivariate analysis of risk factors. Radiother Oncol. 25:1992;31-36
13. Tell R., Sjodin H., Lundell G., et al. Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 39:1997;303-308
14. Liening D.A., Duncan N.O., Blakeslee D.B., et al. Hypothyroidism following radiotherapy for head and neck cancer. Otolaryngol Head Neck Surg. 103:1990;10-13
15. Weissler M.C., Berry B.W. Thyroid-stimulating hormone levels after radiotherapy and combined therapy for head and neck cancer. Head Neck. 13:1991;420-423
16. Sunwoo J.B., Herscher L.L., Kroog G.S., et al. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. J Clin Oncol. 19:2001;800-811
17. Vokes E.E., Weichselbaum R.R., Lippman S.M., et al. Head and neck cancer. N Engl J Med. 328:1993;184-194
18. Tami T.A., Gomez P., Parker G.S., et al. Thyroid dysfunction after radiation therapy in head and neck cancer patients. Am J Otolaryngol. 13:1992;357-362
19. Merino O.R., Lindberg R.D., Fletcher G.H. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 40:1977;145-151
20. Forastiere A., Koch W., Trotti A., et al. Head and neck cancer. N Engl J Med. 345:2001;1890-1900
21. Leon X., Gras J.R., Perez A., et al. Hypothyroidism in patients treated with total laryngectomy. A multivariate study. Eur Arch Otorhinolaryngol. 259:2002;193-196
22. Colevas A.D., Read R., Thornhill J., et al. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 51:2001;599-604
23. Kattlove H., Winn R.J. Ongoing care of patients after primary treatment for their cancer. CA Cancer J Clin. 53:2003;172-196
24. Tunbridge W.M., Evered D.C., Hall R., et al. The spectrum of thyroid disease in a community The Whickham survey. Clin Endocrinol (Oxf). 7:1977;481-493
25. Petersen K., Lindstedt G., Lundberg P.A., et al. Thyroid disease in middle-aged and elderly Swedish women Thyroid-related hormones, thyroid dysfunction and goitre in relation to age and smoking. J Intern Med. 229:1991;407-413
26. Hall EJ. Clinical response of normal tissues. In: Radiobiology for the radiologists. 5th ed. Philadelphia: Lippincott, Williams and Wilkins; 2000. p. 339-360
27. Nofal M.M., Beierwaltes W.H., Patno M.E. Treatment of hyperthyroidism with sodium iodide I-131. Jama. 197:1966;605-610
28. Willemsen U.F., Knesewitsch P., Kreisig T., et al. Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease. Eur J Nucl Med. 20:1993;1051-1055
29. Holm L.E., Lundell G., Israelsson A., et al. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism. J Nucl Med. 23:1982;103-107
30. Withers H.R., Taylor J.M., Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys. 14:1988;751-759
31. Thames H.D. Jr, Withers H.R., Peters L.J., et al. Changes in early and late radiation responses with altered dose fractionation Implications for dose-survival relationships. Int J Radiat Oncol Biol Phys. 8:1982;219-226
32. Fajardo LF, Berthrong M, Anderson RE. Thyroid. In: Radiation pathology: Oxford University Press; 2001. p. 337-343
33. Botnick L.E., Hannon E.C., Hellman S. Multisystem stem cell failure after apparent recovery from alkylating agents. Cancer Res. 38:1978;1942-1947
34. Hellman S., Botnick L.E. Stem cell depletion an explanation of the late effects of cytotoxins. Int J Radiat Oncol Biol Phys. 2:1977;181-184
35. Weichselbaum R.R., Dahlberg W., Little J.B. Inherently radioresistant cells exist in some human tumors. Proc Natl Acad Sci USA. 82:1985;4732-4735
36. Johansen J., Bentzen S.M., Overgaard J., et al. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol. 40:1996;101-109
37. Burnet N.G., Wurm R., Nyman J., et al. Normal tissue radiosensitivity - how important is it? Clin Oncol (R Coll Radiol). 8:1996;25-34
38. Hancock S.L., McDougall I.R., Constine L.S. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys. 31:1995;1165-1170
39. Cutuli B., Quentin P., Rodier J.F., et al. Severe hypothyroidism after chemotherapy and locoregional irradiation for breast cancer. Radiother Oncol. 57:2000;103-105
40. Lundell G., Holm L.E. Hypothyroidism following 131I therapy for hyperthyroidism in relation to immunologic parameters. Acta Radiol Oncol. 19:1980;449-454
41. Demers LM, Spencer CA. Thyrotropin/thyroid stimulating hormone (TSH) measurement. Thyroid 2003;13:33-44
42. Biondi B., Palmieri E.A., Lombardi G., et al. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 137:2002;904-914
43. Kalmijn S., Mehta K.M., Pols H.A., et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf). 53:2000;733-737
44. Parle J.V., Maisonneuve P., Sheppard M.C., et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result A 10-year cohort study. Lancet. 358:2001;861-865
45. Bauer D.C., Ettinger B., Nevitt M.C., et al. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med. 134:2001;561-568
46. Lindstedt G., Nystrom E. Increased risk of bone-fragility-related fractures in TSH-suppressive thyroxine treatment. Läkartidningen. 99:2002;2844-2845
47. Bantle J.P., Lee C.K., Levitt S.H. Thyroxine administration during radiation therapy to the neck does not prevent subsequent thyroid dysfunction. Int J Radiat Oncol Biol Phys. 11:1985;1999-2002
48. Zoberi I., Wasserman T.H., Chao K.S. A prospective, nonrandomized study of the impact of amifostine on subsequent hypothyroidism in irradiated patients with head and neck cancers. Semin Radiat Oncol. 12:2002;14-17
49. Brahme A. Optimized radiation therapy based on radiobiological objectives. Semin Radiat Oncol. 9:1999;35-47